Renin-angiotensin-aldosterone system: a long-term follow-up study in 17 alpha-hydroxylase deficiency syndrome (17OHDS)

Clin Exp Hypertens A. 1986;8(4-5):773-80. doi: 10.3109/10641968609046593.

Abstract

We studied the mineralocorticoid pattern in 4 patients with 17OHD during long-term glucocorticoid treatment. We observed reduction of BP, normalization of K levels, a gradual increase in PRA and in urinary Aldosterone (ALDO); a normal response of plasma ALDO to ACTH and to angiotensin II was present only in one case. We observed a prompt decrease of mineralocorticoid hormones, normalized by long-term therapy only in one case. Discontinuation of treatment induced an increase of ALDO that became suppressed in late off-treatment. Thus, glucocorticoid treatment decreases abnormal steroid levels and activates zona glomerulosa (ZG) function, even if it may take years for ALDO to normalize. Brief discontinuation of therapy induces a surge in ALDO levels, revealing no biosynthetic defect in ZG, while in late off-treatment mineralocorticoids seem to come exclusively from zona fasciculata.

Publication types

  • Case Reports

MeSH terms

  • Adolescent
  • Adrenal Glands / drug effects
  • Adrenal Glands / metabolism
  • Adrenal Hyperplasia, Congenital*
  • Adult
  • Aldosterone / urine
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Hypertension / drug therapy
  • Hypertension / etiology
  • Hypertension / metabolism
  • Male
  • Mineralocorticoids / metabolism
  • Renin / blood
  • Renin-Angiotensin System*
  • Steroid Hydroxylases / deficiency*
  • Syndrome

Substances

  • Glucocorticoids
  • Mineralocorticoids
  • Aldosterone
  • Steroid Hydroxylases
  • Renin